BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 23216230)

  • 1. Hemotherapy bedside biovigilance involving vital sign values and characteristics of patients with suspected transfusion reactions associated with fluid challenges: can some cases of transfusion-associated circulatory overload have proinflammatory aspects?
    Andrzejewski C; Popovsky MA; Stec TC; Provencher J; O'Hearn L; Visintainer P; Steingrub J
    Transfusion; 2012 Nov; 52(11):2310-20. PubMed ID: 23216230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfusion-related acute lung injury and pulmonary edema in critically ill patients: a retrospective study.
    Rana R; Fernández-Pérez ER; Khan SA; Rana S; Winters JL; Lesnick TG; Moore SB; Gajic O
    Transfusion; 2006 Sep; 46(9):1478-83. PubMed ID: 16965572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective review of patient factors, transfusion practices, and outcomes in patients with transfusion-associated circulatory overload.
    Lieberman L; Maskens C; Cserti-Gazdewich C; Hansen M; Lin Y; Pendergrast J; Yi QL; Callum J
    Transfus Med Rev; 2013 Oct; 27(4):206-12. PubMed ID: 24075097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfusion-associated circulatory overload after plasma transfusion.
    Narick C; Triulzi DJ; Yazer MH
    Transfusion; 2012 Jan; 52(1):160-5. PubMed ID: 21762464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfusion-associated circulatory overload in Ireland: a review of cases reported to the National Haemovigilance Office 2000 to 2010.
    Piccin A; Cronin M; Brady R; Sweeney J; Marcheselli L; Lawlor E
    Transfusion; 2015 Jun; 55(6):1223-30. PubMed ID: 25522667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of B-natriuretic peptide as a diagnostic marker in the differential diagnosis of transfusion-associated circulatory overload.
    Zhou L; Giacherio D; Cooling L; Davenport RD
    Transfusion; 2005 Jul; 45(7):1056-63. PubMed ID: 15987348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of fever with transfusion-associated circulatory overload.
    Parmar N; Pendergrast J; Lieberman L; Lin Y; Callum J; Cserti-Gazdewich C
    Vox Sang; 2017 Jan; 112(1):70-78. PubMed ID: 28001310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterizing the epidemiology of perioperative transfusion-associated circulatory overload.
    Clifford L; Jia Q; Yadav H; Subramanian A; Wilson GA; Murphy SP; Pathak J; Schroeder DR; Ereth MH; Kor DJ
    Anesthesiology; 2015 Jan; 122(1):21-8. PubMed ID: 25611653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence, risk factors, and outcome of transfusion-associated circulatory overload in a mixed intensive care unit population: a nested case-control study.
    Bosboom JJ; Klanderman RB; Zijp M; Hollmann MW; Veelo DP; Binnekade JM; Geerts BF; Vlaar APJ
    Transfusion; 2018 Feb; 58(2):498-506. PubMed ID: 29238981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Passive reporting greatly underestimates the rate of transfusion-associated circulatory overload after platelet transfusion.
    Raval JS; Mazepa MA; Russell SL; Immel CC; Whinna HC; Park YA
    Vox Sang; 2015 May; 108(4):387-92. PubMed ID: 25753261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal pro-brain natriuretic peptide is a useful diagnostic marker for transfusion-associated circulatory overload.
    Tobian AA; Sokoll LJ; Tisch DJ; Ness PM; Shan H
    Transfusion; 2008 Jun; 48(6):1143-50. PubMed ID: 18298592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfusion-associated circulatory overload (TACO) and potential risk factors among the inpatient US elderly as recorded in Medicare administrative databases during 2011.
    Menis M; Anderson SA; Forshee RA; McKean S; Johnson C; Holness L; Warnock R; Gondalia R; Worrall CM; Kelman JA; Ball R; Izurieta HS
    Vox Sang; 2014 Feb; 106(2):144-52. PubMed ID: 23848234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and transfusion risk factors for transfusion-associated circulatory overload among medical intensive care unit patients.
    Li G; Rachmale S; Kojicic M; Shahjehan K; Malinchoc M; Kor DJ; Gajic O
    Transfusion; 2011 Feb; 51(2):338-43. PubMed ID: 20723173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes of ABO-incompatible RBC transfusions.
    Janatpour KA; Kalmin ND; Jensen HM; Holland PV
    Am J Clin Pathol; 2008 Feb; 129(2):276-81. PubMed ID: 18208808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multistate cluster of red blood cell transfusion reactions associated with use of a leucocyte reduction filter.
    Alvarado-Ramy F; Kuehnert MJ; Alonso-Echanove J; Sledge L; Haley NR; Epstein J; Vostal J; Pearson M
    Transfus Med; 2006 Feb; 16(1):41-8. PubMed ID: 16480438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-storage leucocyte depletion and transfusion reaction rates in cancer patients.
    Da Ponte A; Bidoli E; Talamini R; Steffan A; Abbruzzese L; Toffola RT; De Marco L
    Transfus Med; 2005 Feb; 15(1):37-43. PubMed ID: 15713127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An association between decreased cardiopulmonary complications (transfusion-related acute lung injury and transfusion-associated circulatory overload) and implementation of universal leukoreduction of blood transfusions.
    Blumberg N; Heal JM; Gettings KF; Phipps RP; Masel D; Refaai MA; Kirkley SA; Fialkow LB
    Transfusion; 2010 Dec; 50(12):2738-44. PubMed ID: 20561296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes and risk factors of transfusion-associated circulatory overload: a case control study.
    Daurat A; Grenie J; Roger C; Daurat G; Cuvillon P; Muller L; Lefrant JY
    Transfusion; 2019 Jan; 59(1):191-195. PubMed ID: 30456761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Volume incompliance and transfusion are essential for transfusion-associated circulatory overload: a novel animal model.
    Klanderman RB; Bosboom JJ; Maas AAW; Roelofs JJTH; de Korte D; van Bruggen R; van Buul JD; Zuurbier CJ; Veelo DP; Hollmann MW; Vroom MB; Juffermans NP; Geerts BF; Vlaar APJ
    Transfusion; 2019 Dec; 59(12):3617-3627. PubMed ID: 31697425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High risk of transfusion-induced alloimmunization of patients with inflammatory bowel disease.
    Papay P; Hackner K; Vogelsang H; Novacek G; Primas C; Reinisch W; Eser A; Mikulits A; Mayr WR; Körmöczi GF
    Am J Med; 2012 Jul; 125(7):717.e1-8. PubMed ID: 22560809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.